Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Revenue (2022 - 2025)

HCW Biologics (HCWB) has disclosed Revenue for 4 consecutive years, with $15607.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue fell 96.34% year-over-year to $15607.0, compared with a TTM value of $422026.0 through Sep 2025, down 87.93%, and an annual FY2024 reading of $2.6 million, down 9.68% over the prior year.
  • Revenue was $15607.0 for Q3 2025 at HCW Biologics, up from $6550.0 in the prior quarter.
  • Across five years, Revenue topped out at $3.1 million in Q1 2022 and bottomed at $5065.0 in Q1 2025.
  • Average Revenue over 4 years is $810526.6, with a median of $618854.0 recorded in 2024.
  • The sharpest move saw Revenue surged 2590.14% in 2024, then crashed 99.55% in 2025.
  • Year by year, Revenue stood at $1.3 million in 2022, then decreased by 1.31% to $1.3 million in 2023, then crashed by 70.18% to $394804.0 in 2024, then crashed by 96.05% to $15607.0 in 2025.
  • Business Quant data shows Revenue for HCWB at $15607.0 in Q3 2025, $6550.0 in Q2 2025, and $5065.0 in Q1 2025.